Cancer
Immunotherapy biomarkers
MMRd vs MSS PDAC
Pancreatic ductal adenocarcinoma
PD-1 inhibition
personalized oncology strategies
PD-1 Inhibition in Pancreatic Cancer: Testing Insights
Recent advancements in oncology have unveiled a pressing need to explore the intricacies of immune checkpoint inhibitors, particularly focusing on PD-1 inhibition in specific cancer types. One such focus has…